Depression

Michael Thase, MD
Using Antipsychotics as an Adjunctive Therapy in Depression
Michael Thase, MD, of the University of Pennsylvania, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.
Machine Learning Uses EEG Data to Predict Antidepressant Response
Researchers have developed a machine learning algorithm that uses electroencephalogram (EEG) data to predict whether a selective serotonin reuptake inhibitor (SSRI) is likely to benefit a patient.
Online Mindfulness-Based Cognitive Therapy Improves Residual Depressive Symptoms
Patients with residual depressive symptoms who received online mindfulness-based cognitive therapy (MBCT) plus usual care demonstrated significant gains in depression and functional outcomes, compared with patients who received usual care only.
Benefits of Psilocybin-Assisted Psychotherapy Last Years in Patients With Cancer
A single dose of psilocybin combined with psychotherapy produced significant improvements in emotional and existential distress in patients with cancer that lasted more than 4 years, according to a published study.
Mental Health Issues in Others May Drive People to Seek Depression Treatment
Knowing someone with emotional or mental health problems increased the likelihood that people who screened positive for depression sought out depression treatment for themselves, according to a study published online in Psychiatric Services.
Quiz: Which Antidepressant Is Used in AXS-05?
AXS-05, which significantly improved symptoms of depression in a recent phase 3 trial, combines dextromethorphan and which antidepressant?
Novel Dextromethorphan-Bupropion Tablet Rapidly Improves Depressive Symptoms
AXS-05, an investigational modulated-delivery tablet combining dextromethorphan and bupropion, significantly improved symptoms of depression in patients with major depressive disorder (MDD) in a recent phase 3 trial, announced developer Axsome Therapeutics Inc.
Cannabinoids Not Justified as Mental Health Treatment, Study Says
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
Teen Depression Risk Lower in Close-Knit Families
Teens with positive family relationships may be less likely to develop depression during adolescence or early adulthood, a new study suggests.
Oral Contraceptives Linked to Depressive Symptoms in Teens
Teenage users of oral contraceptive pills (OCP), particularly 16-year-olds, had higher concurrent depressive symptoms than their nonuser peers in an observational study.
Psilocybin-Assisted Therapy Showing Promise, but More Research Needed
SAN DIEGO—Psilocybin-assisted psychotherapy appears to have a beneficial and lasting effect on patient mood, but possible approval of the treatment remains some time away, a researcher said at Psych Congress 2019.

Audio

ABC News Podcast Features Psych Congress Faculty
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
A Discussion on the Science of Depression
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Back to Top